Clarke, S.J., Chua, W., Moore, M., Kao, S., Phan, V., Tan, C., Charles, K. and McMillan, D.C. (2011) Use of inflammatory markers to guide cancer treatment. Clinical Pharmacology and Therapeutics, 90(3), pp. 475-478. (doi: 10.1038/clpt.2011.122)
Full text not currently available from Enlighten.
Abstract
Patient-related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute-phase proteins C-reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMillan, Professor Donald |
Authors: | Clarke, S.J., Chua, W., Moore, M., Kao, S., Phan, V., Tan, C., Charles, K., and McMillan, D.C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Clinical Specialities |
Journal Name: | Clinical Pharmacology and Therapeutics |
ISSN: | 0009-9236 |
Published Online: | 20 July 2011 |
University Staff: Request a correction | Enlighten Editors: Update this record